HCA Healthcare stock plunges nearly 8% on weak volume trends despite Q1 beat

robot
Abstract generation in progress

HCA Healthcare (NYSE:HCA) shares dropped nearly 8% despite the company reporting first-quarter results that slightly beat analyst expectations, with adjusted EPS of $7.15 and revenue of $19.11 billion. The stock’s decline was attributed to weak volume trends, including a significant decrease in respiratory-related admissions and emergency room visits, and the absence of typical seasonal increases. The company reiterated its full-year 2026 guidance, projecting revenues between $76.5 billion and $80.0 billion, and adjusted EBITDA of $15.55 billion to $16.45 billion.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pin